aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
XLerateHealth focuses on early-stage healthcare startups, particularly in the Midwest and Southeast regions of the United States. They primarily engage in pre-seed and seed investment rounds, offering a nationally recognized 12-week accelerator program to help startups increase their chances of success. The firm's goal is to support impactful healthcare innovation that might otherwise go unrecognized and underfunded.
Notable portfolio companies include Amplified Sciences, Apellis Pharmaceuticals, and RxLightning. XLerateHealth connects startups with clinical, academic, and business leaders to provide comprehensive guidance. Key partners and mentors bring a wealth of expertise from various sectors, enhancing the firm's ability to offer unique value-add services such as strategic advice and industry connections.
Also Known As
Xleratehealth, LLC
Operating Status
Active
XLerateHealth Address
Louisville,
Kentucky
40202
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts